In 2020, AI could empower robotics with tools such as this Brain Bulder workspace. Source: Neurala
For the past decade, robotics has been one of the most interesting areas for developers, industry analysts, and startups to focus on. From emerging technologies and new applications to ongoing challenges, both innovators and entrepreneurs will have a lot to watch in 2020.
The Robot Report spoke with the following executives at robotics and artificial intelligence companies about their observations of 2019s trends, as well as their expectations for the new year:
Which technologies do you expect to mature the most in 2020, such as the Industrial Internet of Things (IIoT), edge computing, 5G wireless networks, or autonomous vehicles?
Visti: In 2020, Industry 4.0 will become more of a reality than a vision. Smart machines keep getting smarter as they get access to more data, and they keep getting better at connecting to other machines and systems, and therefore they become truly useful for manufacturers.
Thomas Visti, Mobile Industrial Robots
While many companies have been hesitant and seen Industry 4.0 as merely a buzzword, were starting to see connected supply chains where MES [manufacturing execution systems], robots, and picking systems are connected.
We also see the connectivity between robots and ERP [enterprise resource planning] systems within production environments.
The entire process from ordering to producing and then transporting goods can now be fully automated. Industry 4.0 is still evolving, and it will not reach its full potential in 2020, but we will see more companies adopting the enabling technologies. This will also influence the workforce, as we will see the same companies wanting to upskill their current workforce and recruit new employees with Industry 4.0 skills.
Versace: Well see more demand for AI that can be trained, deployed, and refined at the edge. 2019 has shown us that many organizations, robotics companies included, are saying No to giving up their data and having to ping the cloud.
I believe that in 2020, AI will need to live and learn at the edge, so that processing occurs where the data is being generated. As a result, robotics companies will see reduced latency problems while mitigating privacy issues and massive cloud fees for manufacturers.
Sudhir Jha, Brighterion
Jha:Enterprises will transition into deploying complex AI models in production at scale. So far, most AI applications are experiments but not in production, simple recommendation/prediction/regression models, or applied to smaller problems.
In 2020, we will see more enterprises getting bolder with their AI ambitions and requiring their vendors to support large deployments.
There will be be an acceleration from automation to autonomy, and AI will play the most crucial role in this. Also, robotics will move further from industrial arena to consumer arena, where they will act as personal coaches, instructors for children, conversational buddies for elders, and guides for the disabled.
Which market or application represents the biggest area of growth potential in 2020?
Visti: We expect to see an increase in the use of robotics in all our existing markets such as automotive, electronics, FMCG [fast-moving consumer goods], pharmaceuticals, and more.
There is still a huge focus on optimization, and with the lack of qualified workers, the need for automation across industries has never been higher.
We expect big growth in the use of AMRs by the 3PL [third-party logistics] segment, which has not been an early adopter of AMRs. In fact, our recent survey showed that only around 50% of 3PLs are currently considering automating internal logistics with AMRs. We expect to see this figure increase significantly in 2020 and the years ahead.
The hospital sector is also looking to automate internal transportation worldwide. For MiR, we have many customers within this segment in Scandinavia and China, but we expect it to grow even more.
Jha: Verticals like healthcare will see expanded AI-based applications, not only in the areas of diagnosis and personalized medicine, but also on the operational side like customer service, payment processing, and FWA (fraud, waste, and abuse).
How will trade conflicts or the slowdown in automotive manufacturing affect robotics in 2020?
Visti: While the automotive manufacturing market may have slowed, the latest statistics from the Robotic Industries Association actually shows what looks like an uptick in ordering of industrial robots by automotive OEMs, up 47% for 2019 over 2018.
Were also experiencing increased growth in that market and overall, with companies like Toyota and Ford purchasing fleets of our AMRs.
We expect this is due to these manufacturers realizing how automation can help fill difficult-to-fill jobs; increase overall productivity; and enable humans to focus on higher-skilled, higher-quality, and higher-paid tasks. These are all benefits that can lead to growth and new job opportunities, which could help turn the automotive industry back around.
Versace: We will always be faced with some degree of socioeconomic uncertainty around the world. In terms of manufacturing, possible decoupling of Chinese and Western economies may actually bolster manufacturing in the U.S. and make it less reliant on overseas production in the long run. This may indirectly boost robotic deployments in the U.S. and Europe.
But at Neurala, were focused on what we can control, which is first and foremost to provide robotics and other companies with an AI platform that they can apply to solve real-world challenges. Our Brain Builder platform is helping organizations accelerate the process of building, deploying, and analyzing AI so they can focus on improving visual inspections.
Related content: Industry experts provide more robotics predictions for 2020
What challenges and opportunities do you expect for AI in 2020?
Jha: As AI-based solutions become more mainstream across industries, we need to carve out a handful domain where our technology provides sustainable differentiation and allows us to be a leader.
We have focused on risk and compliance areas in financial services and are looking to diversify in other verticals. Also our strength in building mission-critical applications in highly regulated industries will serve us well to ensure data privacy and ethical use of AI which is a growing trend globally.
Max Versace, Neurala
Versace: Im thinking of 2020 as the Year of Productization and the Customer.
At Neurala, well continue to work with customers so that they can independently build and deploy custom AI applications for the real world.
Furthermore, AI products such as Brain Builder will enable customers with little or no expertise in AI to build an end-to-end application from scratch, on their proprietary data. This means that enterprises will no longer be restricted by their size or resources when it comes to implementing AI as a part of their business strategies.
Read more from the original source:
In 2020, AI to enable acceleration from automation to autonomy, say experts - Robot Report
- Personalized medicine could transform healthcare - PMC - April 24th, 2025
- Genomic medicine and personalized treatment: a narrative review - April 24th, 2025
- Podcast: Ochre Bios Approach To Precision Medicine In Liver Treatment - insights.citeline.com - April 24th, 2025
- Reinforcement Learning in Personalized Medicine: A Comprehensive Review of Treatment Optimization Strategies - Cureus - April 24th, 2025
- Evolving Biomarkers: Charting the Future of Precision Medicine - MarketScale - April 24th, 2025
- Next Generation Tissue Biomarkers Market Size Report 2030 - Grand View Research - April 24th, 2025
- City of Hope Research on Artificial Intelligence (AI), Precision Medicine, Immunotherapies and Other Topics to be Presented at American Association of... - April 24th, 2025
- What the Newest mRNA Vaccines Could Do Beyond COVID - News-Medical - April 24th, 2025
- Opinion: Where public health ends and personalised medicine begins - Pulse+IT News - April 24th, 2025
- Crohns Disease Treatment Market to Reach $5.9 Billion by 2034, Driven by Biologics & Precision Medicine - Global Banking | Finance | Review - April 24th, 2025
- The Role of High Throughput Screening in Precision Medicine and Market Growth In New Report - WhaTech - April 24th, 2025
- Antiviral Chewing Gum May Prevent Flu and Herpes Transmission - Inside Precision Medicine - April 14th, 2025
- Wisconsin's role in the next advances in health care - BizTimes - April 14th, 2025
- The Future of Pulmonary Fibrosis Management: Precision Medicine, Biomarkers and AI - Managed Healthcare Executive - April 14th, 2025
- Leading Driver In The Jetrea Market 2025: Rise Of Personalized Medicine Fueling Growth - EIN News - March 9th, 2025
- Personalized Medicine Market Overview 2024-2025 & 2030: Oncology, Neurology, and Cardiology Lead Expansion, ext-Generation Sequencing and AI... - March 9th, 2025
- Innovations in core-shell nanoparticles advance drug delivery and precision medicine - Phys.org - March 9th, 2025
- Personalized Medicine: Motivation, Challenges and Progress - February 24th, 2025
- Healthcare innovations in predictive analytics, AI, and personalized medicine - HealthLeaders Media - February 24th, 2025
- Healthcare innovations in predictive analytics, AI, and personalized medicine - Fast Company - February 24th, 2025
- Artificial Intelligence (Ai) In Precision Medicine Market to See Robust Growth from USD 2.14 Billion to USD - EIN News - February 24th, 2025
- BMY: 3 Precision Medicine Stocks That Could Transform Healthcare - StockNews.com - February 24th, 2025
- Cracking Cancers Code: How Genetic Testing Is Changing the Treatment Game - geneonline - February 24th, 2025
- Curt Medeiros on Revolutionizing Precision Medicine and Scaling Ovation - Madrona Venture Group - January 6th, 2025
- Personalized medicine: The pros, cons and concerns - New Atlas - November 16th, 2024
- Precision Medicine, AI, and the Future of Personalized Health Care - November 16th, 2024
- Why precision medicine results in more effective health care, treatment plans - The Business Journals - November 16th, 2024
- Comprehensive Genomic Profiling at Diagnosis Extends Survival in Patients with Advanced Cancer - Inside Precision Medicine - November 16th, 2024
- More Precise Classifications of NonClear Cell RCC Are Required to Improve Personalized Treatment - OncLive - September 13th, 2024
- Bahrain aims to provide residents with personalized healthcare - Healthcare IT News - September 13th, 2024
- Precision Medicine Market Is Expected To Reach Revenue Of - GlobeNewswire - September 13th, 2024
- New Graduates Leverage Genomics Education in Clinical and Research Settings - University of Colorado Anschutz Medical Campus - June 20th, 2024
- Personalized medicine is coming, but who will have access to it? - March 10th, 2024
- Personalized medicine | Definition, Origins, Examples, & Ethical ... - March 10th, 2024
- Innovating for Individual Care: The Impact of USP on Personalized Medicine - March 10th, 2024
- Live Cell Encapsulation Market To Reach USD 313.3 Million at a CAGR of 4% in 2032 - EIN News - April 23rd, 2023
- Cancer Therapeutics and Biotherapeutics Market is estimated to be US$ 506.8 billion by 2032 with a CAGR of - EIN News - April 7th, 2023
- Regenerative Therapies Market is Set to Grow at a CAGR of 8.7% by 2033, Propelled by Advancements in - EIN News - March 13th, 2023
- Gene Therapy Market Size (USD 46.5 Bn by 2030): A Growing Industry and Its Impact on Healthcare Systems - EIN News - March 13th, 2023
- Translating the Microbiome - Inside Precision Medicine - October 15th, 2022
- Enhancing Enrollment in Biomarker-Driven Oncology and Rare Disease Trials - Applied Clinical Trials Online - October 15th, 2022
- Global Cancer/Tumor Profiling Market Research Report to 2027 - Increasing Demand for Personalized Medicine Presents Opportunities -... - October 15th, 2022
- Cambridge biotech raises $168 million to fight cancer and other diseases - The Boston Globe - October 15th, 2022
- Perlmutter Cancer Center Medical Oncologist Provides Personalized Care to People with Breast Cancer - NYU Langone Health - October 15th, 2022
- Concierge Medicine's Continued Rise Illuminated by Specialdocs Consultants at the Industry's Leading Event - PR Newswire - October 15th, 2022
- Hormone Changes: The Star of Every Stage in Women's Sleep - Medscape - October 15th, 2022
- Could Xolair Be the First Biologic Treatment for Food Allergies? - Allergic Living - October 15th, 2022
- Matching Treatments to Your Genes - The Epoch Times - October 15th, 2022
- Global Monoclonal Antibodies (mAbs) Markets, 2018-2021 & 2022-2030 - Increasing R&D Activities Aimed at the Development of Novel Therapeutic mAbs -... - October 15th, 2022
- Xcell Biosciences and aCGT Vector Collaborate to Accelerate Development of Cell and Gene Therapies - Business Wire - October 15th, 2022
- Learn Look Locate Partners with Genetic Testing Leader, Myriad Genetics, in Educational Campaign - PR Newswire - October 15th, 2022
- Important Mission By LG To Reinvent Society With Future Growth - Forbes - October 15th, 2022
- Scientists identify more than 12,000 spots in the human genome associated with height - Inverse - October 15th, 2022
- The future of cancer research | News - ND Newswire - October 15th, 2022
- Kyverna Therapeutics Names Peter Maag, Ph.D., as Chief Executive Officer - PR Newswire - October 15th, 2022
- Call for Accurate Automation in Healthcare Practices to drive the Laboratory Information Systems (LIS) Market | Future Market Insights, Inc. - Yahoo... - October 15th, 2022
- Stem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Ma - Benzinga - October 15th, 2022
- Global Precision Medicine Software Market is projected to witness a healthy growth rate of 10% in the upcoming years - Bio-IT World - July 17th, 2022
- The Single-Cell Analysis Market Size To Almost Double By 2026 Due To A Rising Focus On Personalized Medicine As Per The Business Research Company's... - July 17th, 2022
- Northwell Health Partners with Google Cloud to Provide Proactive, Personalized Healthcare - PR Newswire - July 17th, 2022
- Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research | Scientific... - July 17th, 2022
- New Approaches Needed To Support Digitization Of Healthcare - Forbes - July 17th, 2022
- Outlook on the Microtome Global Market to 2027 - Increasing Demand for Personalized Medicine Presents Opp - Benzinga - July 17th, 2022
- Precision health perspectives - UCI News - July 17th, 2022
- The Worldwide Compound Management Industry is Expected to Reach $1.4 Billion by 2030 - ResearchAndMarkets.com - Business Wire - July 17th, 2022
- Thrive Pet Healthcare and FidoCure Announce An Expansive Pet Precision Health Partnership - Benzinga - Benzinga - July 17th, 2022
- Access to Myriad Genetics GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial - Yahoo... - July 17th, 2022
- Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Rising Applications of iPSCs Fueling Industry Growth - ResearchAndMarkets.com -... - July 17th, 2022
- Research Antibodies and Reagents Market worth $16.1 Billion by 2027 Exclusive Report by MarketsandMarkets - Yahoo Finance - July 17th, 2022
- Global Custom Antibody Market Is Expected To Reach USD 742.27 Million At A CAGR Of 10.3% And Forecast To 2029 - Digital Journal - July 17th, 2022
- Personalized Medicine Coalition - Precision Medicine Advocacy and ... - June 8th, 2022
- Precision Medicine | FDA - June 8th, 2022
- Global Precision Medicine Software Market is anticipated to witness a lucrative CAGR of 10% - GlobeNewswire - June 8th, 2022
- Global Biomarkers Markets Research 2022-2027: Increased Adoption of Biomarkers in Personalized Medicine / Focus on Digital Biomarkers / Increased... - June 8th, 2022
- Every patient in this experimental drug trial saw their cancer disappear, researchers say - CBS News - June 8th, 2022
- The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the... - June 8th, 2022
- It's time to move past Aduhelm and focus on a broader Alzheimer's drug pipeline - STAT - June 8th, 2022
- Can the industry elevate the success rate of cancer trials? - OutSourcing-Pharma.com - June 8th, 2022
- Purdue Polytechnic Institute and Purdue University Global collaborating on partnership with the University of Puerto Rico - Purdue University - June 8th, 2022
- Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions - PR Newswire - June 8th, 2022